Suvretta Capital Management »

SPDR S&P Biotech shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $50M 500k 100.20
2023-03-31 $139M 1.8M 76.21
2016-12-31 $72M 1.2M 59.19

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Benitec Biopharma Com New (BNTC)
Meta Platforms Cl A (META)
Legend Biotech Corp Sponsored Ads (LEGN)
89bio (ETNB)
Immatics SHS (IMTX)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)
Eyepoint Pharmaceuticals Com New (EYPT)
Biohaven (BHVN)
Mineralys Therapeutics (MLYS)
Home Depot (HD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Suvretta Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech